Poster Abstract Session:
161. Influenza and Influenza Vaccines
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Safety of Influenza Vaccination among Hospitalized Patients
Sara Tartof, PhD, MPH; In-Lu Amy Liu, MS; Lei Qian, PhD; Bruno Lewin, MD; Lina S. Sy, MPH; Hung Fu Tseng, PhD, MPH; Rulin Hechter, MD, PhD; Steven Jacobsen, MD, PhD
Influenza Vaccine Effectiveness in the United States during the 2016-17 Season
Brendan Flannery, PhD; Jessie Chung, MPH; Arnold S. Monto, MD, FIDSA; Emily T. Martin, MPH, PhD; Edward Belongia, MD; Huong Q. Mclean, PhD, MPH; Manjusha Gaglani, MBBS; Kempapura Murthy, MBBS, MPH; Richard Zimmerman, MD, MPH; Mary Patricia Nowalk, PhD; Michael L. Jackson, PhD, MPH; Lisa A. Jackson, MD, MPH, FIDSA; Sarah Spencer, PhD; Alicia M. Fry, MD, MPH
Impact of Prior Season Influenza Vaccination on Seasonal Influenza Vaccine Effectiveness: An Analysis over Four Consecutive Seasons from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Michaela Nichols, MSc; Lingyun Ye, MSc; Melissa K Andrew, MD, PhD; Todd Hatchette, MD FRCPC; Ardith Ambrose, RN; Guy Boivin, MD, MSc; William R. Bowie, MD, FRCPC, FIDSA; Gael Dos Santos, PhD; May Elsherif, MD; Karen Green, MSc, RN; Francois Haguinet, PhD; Kevin Katz, MD, CM, MSc, FRCPC; Jason Leblanc, PhD; Mark Loeb, MD, MSc; Donna Mackinnon-Cameron, MMath; Anne Mccarthy, MD; Janet Mcelhaney, MD, FRCPC, FACP; Allison Mcgeer, MD, MSc; Jeff Powis, MD, MSc, FRCPC; David Richardson, MD; Makeda Semret, MD; Rohita Sharma, PhD; Vivek Shinde, MD, MPH; Daniel Smyth, MD, FRCPC; Sylvie Trottier, MD, PhD; Louis Valiquette, MD, MSc, FRCPC; Duncan Webster, MD; Shelly McNeil, MD, FRCPC, FIDSA
Influenza Vaccine Effectiveness Against Influenza-Associated Pneumonia and Pneumococcal Pneumonia in Older Adults: A Prospective Test-Negative Design Study
Motoi Suzuki, MD; Bhim Gopal Dhoubhadel, PhD; Naoko Katsurada, MD; Eiichiro Sando, MD; Tomoko Ishifuji, MD; Norihiro Kaneko, MD; Makito Yaegashi, MD; Naoto Hosokawa, MD; Masahiro Aoshima, MD; Koya Ariyoshi, M.D.; Konosuke Morimoto, M.D., Ph.D.
Posters
  • IDWeek_2017_Suzuki.pdf (403.2 kB)
  • Effectiveness of Influenza Vaccine in Preventing Death among Ontario Residents Aged ≥65 Years during 20 Seasons
    David Shay, MD, MPH; Benjamin Ridenhour, PhD; Michael Campitelli, MSc; Jeffrey C. Kwong, MD
    The Pregnancy Vaccine Effectiveness Network (PREVENT): Establishing a Multi-Country Cohort to Estimate Vaccine Effectiveness (VE) against Hospitalized Influenza during Pregnancy
    Sarah Ball, MPH, ScD; Allison Naleway, PhD; Jeffrey C. Kwong, MD; Annette K. Reagan, PhD, MPH, MinfDis; Kimberley Simmonds, PhD; Becca Feldman, ScD, MS; Eduardo Azziz-Baumgartner, MD, MPH; Brandy Wyant, MPH; Nicola P. Klein, MD, PhD; Deshayne Fell, PhD; Paul Effler, MD, MPH; Stephanie Booth, MPH; Mark Katz, MD; Fatimah S. Dawood, MD; Patricia Shifflett, RN, MS; Michael L. Jackson, PhD, MPH; Sarah Buchan, ScH, MSc; Avram Levy, PhD; Steven Drews, PhD; Shikha Garg, MD, MPH; Stephanie Irving, MHS; Margaret L. Russell, MD PhD; Edwin Lewis, MPH; Bradley Crane, MS; Sharareh Modaressi, MD, MPH; Matthew Slaughter, MSBA; Kristin Goddard, MPH; Mark G. Thompson, PhD
    The Influence of Mandatory Versus Non-Mandatory Influenza Vaccination Policies on Workplace Absenteeism During Respiratory Virus Season
    Michael S. Simberkoff, MD, FIDSA; John Frederick, BA; Alexandria Brown, PhD; Derek Cummings, PhD; Charlotte Gaydos, DrPH, FIDSA; Cynthia Gibert, MD, MSc, FIDSA; Geoffrey Gorse, MD, FIDSA; Ann-Christine Nyquist, MD, MSPH, FPIDS; Trish Perl, MD, MSc, FIDSA, FSHEA; Connie Price, MD; Lewis J. Radonovich, MD, FIDSA; Nicholas Reich, PhD; Maria Rodriguez-Barradas, MD, FIDSA; Mary Bessesen, MD
    Transcriptome Analysis in Human Breast Milk and Blood after Inactivated or Attenuated Influenza Immunization
    Elizabeth P. Schlaudecker, MD, MPH; Johannes Goll, M.S.; Travis Jensen, B.S.; Carey Petrie, PhD; Casey Gelber, MS; Phillip Dexheimer, MS; Mark Steinhoff, MD, FIDSA; David I. Bernstein, MD, MA, FIDSA
    Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses
    Geoffrey J. Gorse, MD, FIDSA; Stephen Grimes, Ph.D.; Helen Buck, Ph.D.; Hussain Mulla, Ph.D.; Peter White, Ph.D.; Irene Graham, MD; John J. Treanor, MD; Heather Hill, MS; Jeanine May, Ph.D.; Peter Blackburn, Ph.D.
    Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥ 45 Years in the United States, 2011-12 to 2015-16
    Fiona P. Havers, MD, MHS; Kate Russell, MD, MPH; Jessie Chung, MPH; Arnold S. Monto, MD, FIDSA; Emily T. Martin, MPH, PhD; Edward A. Belongia, MD; Huong Q. McLean, PhD, MPH; Manjusha Gaglani, MBBS; Kempapura Murthy, MBBS, MPH; Richard K. Zimmerman, MD MPH, FIDSA; Mary Patricia Nowalk, PhD; Michael L. Jackson, PhD, MPH; Lisa A. Jackson, MD, MPH, FIDSA; Brendan L. Flannery, PhD
    Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults: A Systematic Review and Meta-analysis
    Jason Lee, MSc, MBiotech; Gary Lam, PharmD, RPh; Thomas Shin, MA, MPH; Jiyeon Kim, HBsc, PharmD; Anish Krishnan, PharmD; Bruce Seet, PhD, MBA; Dion Neame, MD, BCh, BSc, FRCPC, FAAP; David P. Greenberg, MD, FIDSA, FAAP; Ayman Chit, MBiotech, PhD
    Comparative Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans: 2015-2016 and 2016-2017 Seasons
    Cynthia Lucero-Obusan, MD; Patricia Schirmer, MD; Aaron Wendelboe, Ph.D.; Russell Ryono, Pharm. D.; Gina Oda, MS; Mark Holodniy, MD, FIDSA, FSHEA

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.